Rising
prevalence of vision impartment and eye diseases such as diabetic retinopathy
in geriatric population and diabetes across the globe drive the global market.
Additionally, rising awareness about organ donation and its importance,
especially, in the developing countries likely to propel the market growth.
The
global corneal transplant market Analysis is expected to grow at a CAGR of 10.8% during
the forecast period.
Cost
of corneal transplant varies depending upon the region, availability of
services, and skilled and qualified professionals. Major difference in the cost
is observed, i.e. it is found to be high in the developed countries and low in
developing countries still maintaining qualitative care. Therefore, cost
effective of the treatment would affect the market growth.
Segmental
Analysis:
The
global corneal transplant market is segmented on the basis of type, indication,
and end user.
On
the basis of type, the market is segmented into penetrating keratoplasty,
endothelial keratoplasty, descemet stripping automated endothelial keratoplasty
(DSAEK), corneal graft, corneal limbal stem cell transplant, and others.
On
the basis of indication, the market is segmented into fungal corneal ulcer,
bullous keratopathy, keratoconus, keratitis, corneal stromal dystrophies, and
others.
On
the basis of end user, the market is segmented into hospitals, eye clinics, and
others.
Table of Content
1. Report Prologue
2. Introduction
3. Research Methodology
4. Market Dynamics
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 PORTERS Five Forces
5.3 Demand & Supply:
Gap Analysis
5.4 Pricing Analysis
5.5 Investment Opportunity
Analysis
5.6 Merger And Acquisition
Landscape
5.7 Upcoming Trends
5.7.1 Market Trends
5.7.2 Technological Trends
5.7.3 Insurance &
Regulations
5.7.4 Others
6. Scleritis Market By Types
8. Scleritis Market By Treatment
9. Scleritis Market By Region
...continued
Brows Complete Detailed Research Report at https://www.marketresearchfuture.com/reports/corneal-transplant-market-4525
Competitive Analysis:
Some of
the key players in the global market are CryoLife, Inc. (U.S.), Exactech, Inc.
(U.S.), Köhler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation
(U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.).
Comments
Post a Comment